WENDY REMMERS: Open Payments
NPI 1497181937 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,438 in 70 payments from 19 companies in 2025. Trend: 2023 $1,084 · 2024 $1,146 · 2025 $1,438
Food & beverage: $1,438
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $188 |
| ViiV Healthcare Company | 10 | $183 |
| AstraZeneca Pharmaceuticals LP | 7 | $158 |
| ABBVIE INC. | 7 | $142 |
| Abbott Laboratories | 3 | $115 |
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| Seqirus USA Inc | 2 | $58 |
| PFIZER INC. | 3 | $56 |
Products named: QULIPTA, FREESTYLE LIBRE 3, Ozempic, AIRSUPRA, REXULTI, CABENUVA, APRETUDE, Wegovy.
Industry payments across TN — which companies pay providers there.
